Mir‐301b‐3p Targets Alx4 to Suppress Cisplatin Sensitivity in Breast Cancer through DNA Damage
Advanced Biology · 2026-04 · 10 (4)
DOI: 10.1002/adbi.202500715 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Biology, online erschienen am 07.04.2026. Verfasst von Yan Yan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Radiotherapy Department, The Second People's Hospital of Huai'an, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, Jiangsu, Chi…. Hauptthemen laut MEDLINE: MicroRNAs, Cisplatin, DNA Damage, Breast Neoplasms. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
Objective
To elucidate how ALX Homeobox 4 (ALX4) modulates cisplatin sensitivity via DNA damage regulation in breast cancer (BC), this study explored the established role of mRNA‐mediated DNA repair in driving chemoresistance.
Methods
Integrated bioinformatics and molecular experiments identified ALX4 and miR‐301b‐3p expression patterns in BC cells. Potential binding sites between them were predicted and verified by dual‐luciferase assays. Cellular experiments determined cisplatin IC50 via CCK‐8 assays, while functional impacts of the miR‐301b‐3p/ALX4 axis on proliferation, apoptosis, and cisplatin‐induced DNA damage were assessed using CCK‐8, flow cytometry, alkaline comet assays, and western blot.
Results
Our study identified downregulated ALX4 and upregulated miR‐301b‐3p in BC tissues. miR‐301b‐3p directly targeted ALX4, as confirmed by dual‐luciferase assays. Overexpression of ALX4 inhibited BC cell proliferation, promoted apoptosis, enhanced cisplatin‐induced DNA damage, and increased cisplatin sensitivity. Conversely, miR‐301b‐3p negatively regulated ALX4, thereby modulating DNA damage and cellular response to cisplatin.
Conclusion
This study demonstrates that miR‐301b‐3p promotes BC proliferation and reduces cisplatin sensitivity by suppressing ALX4, a mechanism mediated through the regulation of DNA damage pathways. These findings offer new insights into cisplatin resistance and suggest potential therapeutic targets for overcoming chemoresistance in BC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Radiotherapy Department, The Second People's Hospital of Huai'an, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, Jiangsu, China.
ORCID-Profile: Liqing Zhou
Zitieren
APA
Yan, Y., Xia, J., Ma, T., & Zhou, L. (2026). Mir‐301b‐3p Targets Alx4 to Suppress Cisplatin Sensitivity in Breast Cancer through DNA Damage. Advanced Biology, 10(4). https://doi.org/10.1002/adbi.202500715
Vancouver
Yan Y, Xia J, Ma T, Zhou L. Mir‐301b‐3p Targets Alx4 to Suppress Cisplatin Sensitivity in Breast Cancer through DNA Damage. Advanced Biology. 2026;10(4). doi:10.1002/adbi.202500715
BibTeX
@article{Yan2026,
author = {Yan, Yan and Xia, Jianhong and Ma, Tingting and Zhou, Liqing},
title = {Mir‐301b‐3p Targets Alx4 to Suppress Cisplatin Sensitivity in Breast Cancer through DNA Damage},
journal = {Advanced Biology},
year = {2026},
volume = {10},
number = {4},
doi = {10.1002/adbi.202500715}
}
EUVIMED